pediatric peripheral intravenous infusion
Conditions
Interventions
In the control group (dorsal hand vein cannulation group), cannulation is performed in the dorsal hand vein using a 24-gauge Surflo Flash catheter (Terumo Corporation) according to standard practice.
Sponsors
FUJITA HEALTH UNIVERSITY
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients for whom written informed consent was obtained from a parent or legal guardian after adequate explanation of the study. Pediatric patients aged 6 months to 6 years at the time of enrollment. Patients who require inpatient treatment and are judged to need peripheral intravenous catheter (PIVC) infusion for at least 24 hours.
Exclusion criteria
Exclusion criteria: Patients admitted from departments other than pediatrics. Patients with severe underlying conditions (e.g., cardiac disease, renal disease, or immunodeficiency). Patients receiving intravenous fluids other than lactated Ringer solution with glucose or Soludem No. 2 solution. Patients in whom peripheral intravenous access failed after two attempts. Patients whose catheter was removed within 24 hours after initiation of infusion for medical reasons. Patients deemed inappropriate for inclusion by the principal investigator or co-investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the incidence of catheter failure (CF) between the two techniques and to determine which is superior in terms of infusion completion rates. | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) To compare the first-attempt success rate, number of insertion attempts, and catheter dwell time between the two groups. (2) To evaluate the association between catheter failure (CF) and anatomical factors (e.g., vessel diameter, depth, and distance from joints), as well as clinical factors (e.g., age and type of infusate). | — |
Countries
Japan
Contacts
Public Contactkatsuyuki yokoi
FUJITA HEALTH UNIVERSITY OKAZAKI MEDICAL CENTER pediatrics
Outcome results
None listed